Résumé
<p><b>OBJECTIVE</b>To observe the clinical efficacy of Qianlie Sanyu Capsule on benign prostatic hyperplasia (BPH).</p><p><b>METHODS</b>Seventy-two patients with BPH were randomly divided into a treatment group (40 patients) and a control group (32 patients), the former treated by Qianlie Sanyu Capsule and the latter by Longbishu. Observation were made on the changes of the patients' urination' symptoms, living quality, prostatic volume, Qmax uroflowmetry and excel urine before and after treatment.</p><p><b>RESULTS</b>The total efficacy rates were 92.5% in the treatment group, and 72.5% in the control group. Comparison between the two groups showed significant difference (P < 0.01). The urination symptoms, living quality, Qmax uroflowmetry and the excel urine were better improved in the Qianlie Sanyu group than in the Longbishu. There were significant differences between the two groups (P < 0.05), but none in reducing effect on the prostatic volume.</p><p><b>CONCLUSION</b>Qianlie Sanyu Capsule is an effective drug for BPH.</p>